{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T02:57:30Z","timestamp":1790737050990,"version":"4.1.0"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81803793"],"award-info":[{"award-number":["81803793"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.intimp.2025.116105","type":"journal-article","created":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T00:52:48Z","timestamp":1767574368000},"page":"116105","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Schisandrin B inhibits hepatic inflammation and steatosis via activation of pregnane X receptor signaling in methionine and choline-deficient high fat diet-induced steatohepatitis mouse model"],"prefix":"10.1016","volume":"171","author":[{"given":"Chun Yu","family":"Gu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li Shan","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi Shan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia Jia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen Ling","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi Ling","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10290","key":"10.1016\/j.intimp.2025.116105_bb0005","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/S0140-6736(20)32511-3","article-title":"Non-alcoholic fatty liver disease","volume":"397","author":"Powell","year":"2021","journal-title":"Lancet (London, England)."},{"issue":"3","key":"10.1016\/j.intimp.2025.116105_bb0010","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/s41573-024-01084-2","article-title":"Therapeutic landscape of metabolic dysfunction-associated steatohepatitis (MASH)","volume":"24","author":"Do","year":"2025","journal-title":"Nat. Rev. Drug Discov."},{"issue":"4","key":"10.1016\/j.intimp.2025.116105_bb0015","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","article-title":"The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review","volume":"77","author":"Younossi","year":"2023","journal-title":"Hepatology (Baltimore, Md)."},{"issue":"4","key":"10.1016\/j.intimp.2025.116105_bb0020","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.jhep.2018.05.036","article-title":"Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030","volume":"69","author":"Estes","year":"2018","journal-title":"J. Hepatol."},{"issue":"6","key":"10.1016\/j.intimp.2025.116105_bb0025","doi-asserted-by":"crossref","first-page":"3244","DOI":"10.1074\/jbc.M113.494575","article-title":"Role of pregnane X receptor in obesity and glucose homeostasis in male mice","volume":"289","author":"Spruiell","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.intimp.2025.116105_bb0030","article-title":"Dual Role of Pregnane X Receptor in Nonalcoholic Fatty Liver Disease","volume":"17","author":"Xu","year":"2024","journal-title":"Curr Mol Pharmacol."},{"issue":"2","key":"10.1016\/j.intimp.2025.116105_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.molpha.2024.100014","article-title":"Insights of direct and indirect regulation of PXR through phosphorylation in fatty liver disease","volume":"107","author":"Basaly","year":"2025","journal-title":"Mol. Pharmacol."},{"issue":"4","key":"10.1016\/j.intimp.2025.116105_bb0040","doi-asserted-by":"crossref","first-page":"G1114","DOI":"10.1152\/ajpgi.00528.2006","article-title":"Pregnane X receptor activation ameliorates DSS-induced inflammatory bowel disease via inhibition of NF-kappaB target gene expression","volume":"292","author":"Shah","year":"2007","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"2\u20133","key":"10.1016\/j.intimp.2025.116105_bb0045","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jsbmb.2010.04.012","article-title":"The PXR is a drug target for chronic inflammatory liver disease","volume":"120","author":"Wallace","year":"2010","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"3","key":"10.1016\/j.intimp.2025.116105_bb0050","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1124\/dmd.114.062307","article-title":"Pregnane X receptor modulates the inflammatory response in primary cultures of hepatocytes","volume":"43","author":"Sun","year":"2015","journal-title":"Drug Metab. Dispos."},{"issue":"4","key":"10.1016\/j.intimp.2025.116105_bib341","doi-asserted-by":"crossref","first-page":"310","DOI":"10.2174\/138920008784220664","article-title":"Drugs behave as substrates, inhibitors and inducers of human cytochrome P450 3A4","volume":"9","author":"Zhou","year":"2008","journal-title":"Curr Drug Metab."},{"issue":"3","key":"10.1016\/j.intimp.2025.116105_bb0060","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.cgh.2006.12.021","article-title":"Association between nonalcoholic hepatic steatosis and hepatic cytochrome P-450 3A activity","volume":"5","author":"Kolwankar","year":"2007","journal-title":"Clinical gastroenterology and hepatology: the official clinical practice journal of the American Gastroenterological Association."},{"issue":"4","key":"10.1016\/j.intimp.2025.116105_bb0065","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1124\/mol.116.104687","article-title":"A Fibroblast Growth Factor 21-Pregnane X Receptor Pathway Downregulates Hepatic CYP3A4 in Nonalcoholic Fatty Liver Disease","volume":"90","author":"Woolsey","year":"2016","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.intimp.2025.116105_bb0070","doi-asserted-by":"crossref","first-page":"2172740","DOI":"10.1155\/2020\/2172740","article-title":"A Comprehensive Review on Schisandrin B and Its Biological Properties","volume":"2020","author":"Nasser","year":"2020","journal-title":"Oxidative Med. Cell. Longev."},{"issue":"3","key":"10.1016\/j.intimp.2025.116105_bb0075","first-page":"735","article-title":"Schisandrin B ameliorates non-alcoholic liver disease through anti-inflammation activation in diabetic mice","volume":"83","author":"Ma","year":"2022","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.intimp.2025.116105_bb0080","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.2147\/DDDT.S137507","article-title":"Schisandrin B attenuates CCl4-induced liver fibrosis in rats by regulation of Nrf2-ARE and TGF-\u03b2\/Smad signaling pathways","volume":"11","author":"Chen","year":"2017","journal-title":"Drug Des. Devel. Ther."},{"issue":"19","key":"10.1016\/j.intimp.2025.116105_bb0085","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.21037\/atm-21-4602","article-title":"Schisandrin B regulates macrophage polarization and alleviates liver fibrosis via activation of PPAR\u03b3","volume":"9","author":"Chen","year":"2021","journal-title":"Ann Transl Med."},{"key":"10.1016\/j.intimp.2025.116105_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2022.155200","article-title":"Schisandrin B mitigates hepatic steatosis and promotes fatty acid oxidation by inducing autophagy through AMPK\/mTOR signaling pathway","volume":"131","author":"Yan","year":"2022","journal-title":"Metab. Clin. Exp."},{"key":"10.1016\/j.intimp.2025.116105_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2025.119801","article-title":"Schisandra chinensis lignans ameliorate hepatic inflammation and steatosis in methionine choline-deficient diet-fed mice by modulating the gut-liver axis","volume":"348","author":"Yan","year":"2025","journal-title":"J. Ethnopharmacol."},{"issue":"2","key":"10.1016\/j.intimp.2025.116105_bb0100","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3390\/v17020175","article-title":"NAD+ Suppresses EV-D68 Infection by Enhancing Anti-Viral Effect of SIRT","volume":"17","author":"Wang","year":"2025","journal-title":"Viruses"},{"issue":"2","key":"10.1016\/j.intimp.2025.116105_bb0105","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.intimp.2025.116105_bb0110","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/978-1-59745-019-5_13","article-title":"Isolation and culture of adult mouse hepatocytes","volume":"633","author":"Li","year":"2010","journal-title":"Methods. Mol. Biol. (Clifton, N.J.)"},{"key":"10.1016\/j.intimp.2025.116105_bb0115","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.3389\/fphar.2019.01666","article-title":"Edgeworthia gardneri (Wall.) Meisn. Water Extract Ameliorates Palmitate Induced Insulin Resistance by Regulating IRS1\/GSK3\u03b2\/FoxO1 Signaling Pathway in Human HepG2 Hepatocytes","volume":"10","author":"Zhang","year":"2019","journal-title":"Front. Pharmacol."},{"issue":"6","key":"10.1016\/j.intimp.2025.116105_bb0340","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.2337\/db12-1039","article-title":"PXR ablation alleviates diet-induced and genetic obesity and insulin resistance in mice","volume":"62","author":"He","year":"2013","journal-title":"Diabetes"},{"issue":"7","key":"10.1016\/j.intimp.2025.116105_bb0120","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/s41575-019-0145-7","article-title":"From NASH to HCC: current concepts and future challenges","volume":"16","author":"Anstee","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"12","key":"10.1016\/j.intimp.2025.116105_bb0125","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1038\/s42255-022-00700-y","article-title":"A researcher\u2019s guide to preclinical mouse NASH models","volume":"4","author":"Gallage","year":"2022","journal-title":"Nat. Metab."},{"issue":"2","key":"10.1016\/j.intimp.2025.116105_bb0130","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1097\/MOG.0b013e32834e7b4b","article-title":"Choline metabolism provides novel insights into nonalcoholic fatty liver disease and its progression","volume":"28","author":"Corbin","year":"2012","journal-title":"Curr. Opin. Gastroenterol."},{"issue":"1","key":"10.1016\/j.intimp.2025.116105_bb0135","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/path.4829","article-title":"Animal models of non-alcoholic fatty liver disease: current perspectives and recent advances","volume":"241","author":"Lau","year":"2017","journal-title":"J. Pathol."},{"key":"10.1016\/j.intimp.2025.116105_bb0140","doi-asserted-by":"crossref","first-page":"9584932","DOI":"10.1155\/2017\/9584932","article-title":"Oxidation Resistance of the Sulfur Amino Acids: Methionine and Cysteine","volume":"2017","author":"Bin","year":"2017","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.intimp.2025.116105_bb0145","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s42826-019-0016-y","article-title":"Comparative study of liver injury induced by high-fat methionine- and choline-deficient diet in ICR mice originating from three different sources","volume":"35","author":"Lee","year":"2019","journal-title":"Laboratory animal research."},{"issue":"2","key":"10.1016\/j.intimp.2025.116105_bb0150","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/iep.12008","article-title":"An improved mouse model that rapidly develops fibrosis in non-alcoholic steatohepatitis","volume":"94","author":"Matsumoto","year":"2013","journal-title":"Int. J. Exp. Pathol."},{"issue":"3","key":"10.1016\/j.intimp.2025.116105_bb0155","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1211\/jpp.60.3.0017","article-title":"Schisandrin B from Schisandra chinensis reduces hepatic lipid contents in hypercholesterolaemic mice","volume":"60","author":"Pan","year":"2008","journal-title":"J. Pharm. Pharmacol."},{"issue":"24","key":"10.1016\/j.intimp.2025.116105_bb0160","doi-asserted-by":"crossref","first-page":"21851","DOI":"10.1074\/jbc.M301982200","article-title":"A gender-specific role for phosphatidylethanolamine N-methyltransferase-derived phosphatidylcholine in the regulation of plasma high density and very low density lipoproteins in mice","volume":"278","author":"Noga","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.intimp.2025.116105_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2023.175618","article-title":"Polyunsaturated fatty acids drive neutrophil extracellular trap formation in nonalcoholic steatohepatitis","volume":"945","author":"Wu","year":"2023","journal-title":"Eur. J. Pharmacol."},{"issue":"9","key":"10.1016\/j.intimp.2025.116105_bb0170","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1194\/jlr.M083741","article-title":"Oxidized linoleic acid metabolites induce liver mitochondrial dysfunction, apoptosis, and NLRP3 activation in mice","volume":"59","author":"Schuster","year":"2018","journal-title":"J. Lipid Res."},{"issue":"2","key":"10.1016\/j.intimp.2025.116105_bb0175","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1529","article-title":"DEAD-Box Helicase 17 exacerbates non-alcoholic steatohepatitis via transcriptional repression of cyp2c29, inducing hepatic lipid metabolism disorder and eliciting the activation of M1 macrophages","volume":"14","author":"Ning","year":"2024","journal-title":"Clin. Transl. Med."},{"issue":"2","key":"10.1016\/j.intimp.2025.116105_bb0180","doi-asserted-by":"crossref","first-page":"401","DOI":"10.20892\/j.issn.2095-3941.2019.0335","article-title":"Time serial transcriptome reveals Cyp2c29 as a key gene in hepatocellular carcinoma development","volume":"17","author":"Wang","year":"2020","journal-title":"Cancer Biol. Med."},{"key":"10.1016\/j.intimp.2025.116105_bib342","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2024.101957","article-title":"Suppression of hepatic ChREBP\u237a-CYP2C50 axis-driven fatty acid oxidation sensitizes mice to diet-induced MASLD\/MASH","volume":"85","author":"Zhang","year":"2024","journal-title":"Mol Metab."},{"issue":"1","key":"10.1016\/j.intimp.2025.116105_bb0185","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/s41392-020-00443-w","article-title":"Metabolism pathways of arachidonic acids: mechanisms and potential therapeutic targets","volume":"6","author":"Wang","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"issue":"5","key":"10.1016\/j.intimp.2025.116105_bb0190","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.363","article-title":"Arachidonic acid metabolism in health and disease","volume":"4","author":"Zhang","year":"2023","journal-title":"MedComm"},{"issue":"1","key":"10.1016\/j.intimp.2025.116105_bb0195","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1006\/abbi.1998.0806","article-title":"Cloning and expression of murine CYP2Cs and their ability to metabolize arachidonic acid","volume":"357","author":"Luo","year":"1998","journal-title":"Arch. Biochem. Biophys."},{"issue":"5","key":"10.1016\/j.intimp.2025.116105_bb0200","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1124\/mol.65.5.1148","article-title":"Cloning, expression, and characterization of three new mouse cytochrome p450 enzymes and partial characterization of their fatty acid oxidation activities","volume":"65","author":"Wang","year":"2004","journal-title":"Mol. Pharmacol."},{"issue":"7","key":"10.1016\/j.intimp.2025.116105_bb0205","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1124\/dmd.117.075697","article-title":"Characterization of the Tissue Distribution of the Mouse Cyp2c Subfamily by Quantitative PCR Analysis","volume":"45","author":"Graves","year":"2017","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.intimp.2025.116105_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114732","article-title":"Role of eicosanoids in liver repair, regeneration and cancer","volume":"192","author":"Alvarez","year":"2021","journal-title":"Biochem. Pharmacol."},{"issue":"4","key":"10.1016\/j.intimp.2025.116105_bb0215","first-page":"285","article-title":"The role of cytochrome P450 in nonalcoholic fatty liver induced by high-fat diet: a gene expression profile analysis","volume":"25","author":"Liu","year":"2017","journal-title":"Chin. J. Hepatol."},{"issue":"5","key":"10.1016\/j.intimp.2025.116105_bb0220","first-page":"744","article-title":"Mechanism of miRNA-3679 Inhibiting Downstream ZADH2-Target Genes to Promote Hepatocellular Carcinoma Cell Proliferation","volume":"53","author":"He","year":"2022","journal-title":"Journal of Sichuan University Medical science edition."},{"issue":"1","key":"10.1016\/j.intimp.2025.116105_bb0225","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1517\/14728222.2013.843671","article-title":"Targeting leukotriene B4 in inflammation","volume":"18","author":"Di Gennaro","year":"2014","journal-title":"Expert Opin. Ther. Targets"},{"issue":"3","key":"10.1016\/j.intimp.2025.116105_bb0230","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s11306-018-1326-z","article-title":"Omega-6-derived oxylipin changes in serum of patients with hepatitis B virus-related liver diseases","volume":"14","author":"Lu","year":"2018","journal-title":"Metabolomics: Official journal of the Metabolomic Society"},{"issue":"9","key":"10.1016\/j.intimp.2025.116105_bb0235","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3390\/metabo9090177","article-title":"Oxylipin Profiling of Alzheimer\u2019s Disease in Nondiabetic and Type 2 Diabetic Elderly","volume":"9","author":"Morris","year":"2019","journal-title":"Metabolites"},{"key":"10.1016\/j.intimp.2025.116105_bb0240","doi-asserted-by":"crossref","DOI":"10.1177\/1756284820923904","article-title":"Plasma eicosanoids as noninvasive biomarkers of liver fibrosis in patients with nonalcoholic steatohepatitis","volume":"13","author":"Caussy","year":"2020","journal-title":"Ther. Adv. Gastroenterol."},{"issue":"2","key":"10.1016\/j.intimp.2025.116105_bb0245","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.jhep.2023.10.025","article-title":"CD1d protects against hepatocyte apoptosis in non-alcoholic steatohepatitis","volume":"80","author":"Lei","year":"2024","journal-title":"J. Hepatol."},{"issue":"26","key":"10.1016\/j.intimp.2025.116105_bb0250","doi-asserted-by":"crossref","first-page":"17552","DOI":"10.1074\/jbc.M600950200","article-title":"Gadd45a and Gadd45b protect hematopoietic cells from UV-induced apoptosis via distinct signaling pathways, including p38 activation and JNK inhibition","volume":"281","author":"Gupta","year":"2006","journal-title":"J. Biol. Chem."},{"issue":"11","key":"10.1016\/j.intimp.2025.116105_bb0260","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.3390\/genes12111694","article-title":"Cathepsin C Regulates Cytokine-Induced Apoptosis in \u03b2-Cell Model Systems","volume":"12","author":"Fl\u00f8yel","year":"2021","journal-title":"Genes"},{"issue":"44","key":"10.1016\/j.intimp.2025.116105_bib344","doi-asserted-by":"crossref","first-page":"45495","DOI":"10.1074\/jbc.M406933200","article-title":"CHOP is involved in endoplasmic reticulum stress-induced apoptosis by enhancing DR5 expression in human carcinoma cells","volume":"279","author":"Yamaguchi","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.intimp.2025.116105_bib343","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/s41418-024-01385-4","article-title":"DNA damage-inducible transcript 3 positively regulates RIPK1-mediated necroptosis","volume":"32","author":"Ni","year":"2025","journal-title":"Cell Death Differ."},{"issue":"6463","key":"10.1016\/j.intimp.2025.116105_bb0265","doi-asserted-by":"crossref","first-page":"eaar5551","DOI":"10.1126\/science.aar5551","article-title":"Sphingosine 1-phosphate: Lipid signaling in pathology and therapy","volume":"366","author":"Cartier","year":"2019","journal-title":"Science (New York, N.Y.)"},{"issue":"1","key":"10.1016\/j.intimp.2025.116105_bb0270","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S0168-8278(99)80158-5","article-title":"A possible role of nuclear ceramide and sphingosine in hepatocyte apoptosis in rat liver","volume":"31","author":"Tsugane","year":"1999","journal-title":"J. Hepatol."},{"key":"10.1016\/j.intimp.2025.116105_bb0275","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev.pharmtox.42.111901.111051","article-title":"Regulation of cyp3a gene transcription by the pregnane x receptor","volume":"42","author":"Goodwin","year":"2002","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"issue":"4","key":"10.1016\/j.intimp.2025.116105_bb0280","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.bbrc.2010.02.058","article-title":"Regulation of CYP3A4 by pregnane X receptor: The role of nuclear receptors competing for response element binding","volume":"393","author":"Istrate","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.intimp.2025.116105_bb0285","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.lfs.2017.03.012","article-title":"Palmitic acid elicits hepatic stellate cell activation through inflammasomes and hedgehog signaling","volume":"176","author":"Duan","year":"2017","journal-title":"Life Sci."},{"issue":"17","key":"10.1016\/j.intimp.2025.116105_bb0290","doi-asserted-by":"crossref","first-page":"13222","DOI":"10.3390\/ijms241713222","article-title":"Saturated Fat-Mediated Upregulation of IL-32 and CCL20 in Hepatocytes Contributes to Higher Expression of These Fibrosis-Driving Molecules in MASLD","volume":"24","author":"Schilcher","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2025.116105_bb0295","author":"Pinilla"},{"key":"10.1016\/j.intimp.2025.116105_bb0305","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2021.101349","article-title":"The hepatocyte IKK:NF-\u03baB axis promotes liver steatosis by stimulating de novo lipogenesis and cholesterol synthesis","volume":"54","author":"Heida","year":"2021","journal-title":"Molecular Metabolism."},{"key":"10.1016\/j.intimp.2025.116105_bb0315","doi-asserted-by":"crossref","first-page":"8071093","DOI":"10.1155\/2018\/8071093","article-title":"Liver X Receptor Inverse Agonist SR9243 Suppresses Nonalcoholic Steatohepatitis Intrahepatic Inflammation and Fibrosis","volume":"2018","author":"Huang","year":"2018","journal-title":"Biomed. Res. Int."},{"issue":"3","key":"10.1016\/j.intimp.2025.116105_bb0320","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1021\/cb300541g","article-title":"A liver-selective LXR inverse agonist that suppresses hepatic steatosis","volume":"8","author":"Griffett","year":"2013","journal-title":"ACS Chem. Biol."},{"issue":"4","key":"10.1016\/j.intimp.2025.116105_bb0325","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.molmet.2015.01.009","article-title":"The LXR inverse agonist SR9238 suppresses fibrosis in a model of non-alcoholic steatohepatitis","volume":"4","author":"Griffett","year":"2015","journal-title":"Molecular Metabolism."},{"issue":"25","key":"10.1016\/j.intimp.2025.116105_bib345","doi-asserted-by":"crossref","first-page":"15639","DOI":"10.1074\/jbc.273.25.15639","article-title":"Steatohepatitis, spontaneous peroxisome proliferation and liver tumors in mice lacking peroxisomal fatty acyl-CoA oxidase. Implications for peroxisome proliferator-activated receptor alpha natural ligand metabolism","volume":"273","author":"Fan","year":"1998","journal-title":"J Biol Chem."},{"key":"10.1016\/j.intimp.2025.116105_bib346","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.826628","article-title":"Aurantio-Obtusin Attenuates Non-Alcoholic Fatty Liver Disease Through AMPK-Mediated Autophagy and Fatty Acid Oxidation Pathways","volume":"12","author":"Zhou","year":"2022","journal-title":"Front Pharmacol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925020946?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925020946?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T01:29:23Z","timestamp":1769131763000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576925020946"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":68,"alternative-id":["S1567576925020946"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2025.116105","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Schisandrin B inhibits hepatic inflammation and steatosis via activation of pregnane X receptor signaling in methionine and choline-deficient high fat diet-induced steatohepatitis mouse model","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2025.116105","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116105"}}